The AMES Rehab Therapy Medical
Device with a Food and Drug Administration (FDA) 510(k) Class II clearance to
market and sell to hospitals and rehabilitation clinics, is currently being operated in a limited number of hospitals to
treat persons whose movement is severely limited as a result of diseases of and
injuries to the brain and spinal cord.
A 510(k) Class II Clearance
from the FDA, to market and sell the AMES R300 Rehab Therapy Device, was
received on May 24, 2013.